AUS
NZ
UK
CA
USA
IND
Healthcare
Race Oncology initiates Australian site for Phase I solid tumour trial
March 28, 2025 07:09 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology Ltd establishes an Australian clinical site for its Phase 1 trial.,The study focuses on testing RC220 in combination with chemotherapy.,Trial to assess safety, dosage, and impact on cancer progression.,Race Oncology Ltd has...
Innovative Cancer Treatment Progress: Race Oncology (ASX:RAC) Advances in Chemotherapy Reformulation
March 28, 2025 03:03 PM AEDT| By Team Kalkine MediaHighlights,Race Oncology is advancing a safer chemotherapy alternative.,Clinical,trials to,explore reduced side effects and enhanced efficacy.,Potential for improved patient safety and outcomes in cancer care.,Race Oncology is spearheading a groundbr...
Race launches initial site for Phase I trial of a cardioprotective anticancer drug.
March 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Southside Cancer Care Centre in Miranda has been established as the initial site for the Phase I trial of RC220.,The trial includes participants with advanced solid tumors across Australia, Hong Kong, and South Korea.,RC220 is developed wi...
Compumedics Gains Traction in China with Brain Mapping Technology
March 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Compumedics announces a new deal with Hangzhou Normal University for its Orion LifeSpan MEG system.,The agreement adds to previous installations, expanding the company’s reach in China’s neuroimaging field.,The order includes advanced neur...
Artrya Limited Achieves Milestone with FDA Clearance for Groundbreaking Cardiac Technology
March 28, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Artrya Limited (AYA) secures FDA clearance for its Salix® Coronary Anatomy.,Strategic partnerships set to boost U.S. commercialization.,New technology promises a proactive approach in coronary diagnostics.,Artrya Limited (ASX:AYA) has rece...
Analyzing ResMed CDI’s (ASX:RMD) Financial and Market Performance
March 28, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,ResMed CDI (RMD) navigates a market downturn with robust financial health.,Innovation and global presence sustain ResMed’s industry dominance.,ResMed’s shares trade below historical averages, hinting at potential under-valuation.,In the ev...
Healius (ASX:HLS) Charts Future with Bold Pathology Strategy and Substantial Dividend Announcement
March 27, 2025 03:40 PM AEDT| By Team Kalkine MediaHighlights,Healius,(HLS) unveils a robust Pathology Strategy with,potential,high EBIT margins.,Announces special $300 million dividend following a strategic sale.,Forecasts enhanced financial health with strategic focus on operational efficiencies.,I...
Should You Be Concerned About EBR Systems' (EBR) Debt Despite the Lack of Earnings?
March 27, 2025 03:31 PM AEDT| By Team Kalkine MediaShould You Be Concerned About EBR Systems' (EBR) Debt Despite the Lack of Earnings?
Mesoblast begins Ryoncil sales in the US as shareholders remain eager for revenue.
March 27, 2025 12:30 PM AEDT| By Team Kalkine MediaMesoblast begins Ryoncil sales in the US as shareholders remain eager for revenue.
Produced in Australia: ASX Companies Enhancing Domestic Health and Medical Manufacturing
March 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Government initiatives and industry investments are strengthening domestic medical manufacturing.,Prominent companies like CSL, ResMed, and Cochlear are driving innovation and expansion.,The sector is benefiting from local policies fosteri...
EMVision Launches Crucial Trial for Emu Brain Scanner to Diagnose Stroke
March 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,EMVision Medical Devices (ASX:EMV) has commenced a pivotal validation trial for its EMU bedside brain scanner.,Trial sites include the Royal Melbourne Hospital and University of Texas Health Science Center at Houston.,The study is designed...
CleanSpace Holdings Limited's (ASX:CSX) Recent Stock Performance and Valuation Insights
March 27, 2025 09:31 AM AEDT| By Team Kalkine MediaHighlights,CleanSpace Holdings Limited (ASX:CSX) experienced a sharp rise in stock value.,Despite the jump, its P/S ratio remains low compared to industry averages.,Future growth expectations are pivotal in understanding its current valuation.,CleanS...
Neuren Pharmaceuticals Advances on Lifesaving Pediatric Treatment
March 27, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Neuren Pharmaceuticals progresses with a pivotal new treatment for infants.,Upcoming discussions with the FDA mark a significant step forward.,The treatment targets a major cause of neonatal death.,Neuren Pharmaceuticals (ASX:NEU) is takin...
Healius (ASX:HLS) Surges After Announcing Lucrative Dividend Post-Subsidiary Sale
March 27, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Healius (ASX:HLS) shares surged 14.5% following a special dividend announcement.,The dividend is announced after the $300 million sale of Lumus Imaging.,Shareholders to receive a full-franked special dividend of $4.13 per share.,Pathology...
Clinuvel Pharmaceuticals Announces Extended Share Repurchase Initiative
March 27, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Clinuvel Pharmaceuticals (CUV) extends its share repurchase program for another year.,Plans to repurchase an additional 1.5 million shares, about 3% of the outstanding share capital.,The initiative highlights Clinuvel’s commitment to sound...
The morning catch up: ASX on the green as small and mid cap companies present their wares at the ASX SMIDcaps Conference
March 26, 2025 07:32 PM AEDT| By Team Kalkine MediaHighlights:,ASX 200,records a steady performance amid sector shifts.,Healthcare Stocks,gain traction with new product launches.,Small and mid-cap companies showcase innovations at the ASX SMIDcaps Conference.,The,ASX 200,maintained stability with sec...
Prescient Therapeutics opens first clinical site for Phase 2a PTX-100 trial in cutaneous T-cell lymphoma
March 26, 2025 07:29 PM AEDT| By Team Kalkine MediaHighlights,Prescient Therapeutics Ltd (ASX,:PTX,, OTC,:PSTTF,),initiates a Phase 2a clinical trial for PTX-100 in cutaneous T-cell lymphoma.,The first study site has been established at Epworth Freemasons Haematology Clinical Trial Unit.,PTX-100 is a...
Clinuvel's Stroke Drug Trial Reports Positive Findings
March 26, 2025 06:34 PM AEDT| By Team Kalkine MediaHighlights:,ASX 200, Healthcare Stocks,gain attention as Clinuvel (ASX:CUV) reports trial progress.,Stroke drug,PRENUMBRA,demonstrates a favorable safety profile.,Clinical data aligns with prior research on afamelanotide.,Clinuvel Pharmaceuticals (AS...
Top of mind: ASX companies tackling neurological disorders
March 26, 2025 06:24 PM AEDT| By Team Kalkine MediaHighlights:,Several,ASX 200,healthcare stocks are focusing on treatments for neurological disorders.,The neurological drug development landscape is evolving with new clinical trials.,Regulatory advancements are fostering growth in research for brain-...
Assessing Pro Medicus as a Defensive ASX Stock
March 26, 2025 05:42 PM AEDT| By Team Kalkine MediaAssessing Pro Medicus as a Defensive ASX Stock
Advertise your brand on Kalkine Media